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Abstract 
Background: During the COVID-19 pandemic tele-health modalities have come to prominence 
as a strategy for providing patient care when in-person care provision opportunities are 
limited.  The degree of adoption by neuro-ophthalmologists has not been quantified. 
Methods: Telehealth utilization pre- and peri-COVID-19 was surveyed among practicing neuro-
ophthalmologists in and outside the US using an on-line platform.  Demographics, perceived 
benefits, barriers, and utility for different neuro-ophthalmic conditions were collected.  Data 
collection occurred over a 2-week period in May, 2020. 
Results: 208 practicing neuro-ophthalmologists (81.3% US, 50.2% female, age range < 35 to > 
65, mode 35-44 years) participated in the survey. Utilization of all telehealth modalities 
increased from pre-COVID to peri-COVID (video visit 3.9% to 68.3%, p<0.0005, remote 
interpretation of testing 26.7% to 32.2%, p=0.09, on-line second opinion 7.9% to 15.3%, 
p=0.001, interprofessional e-consult 4.4% to 18.7%, p<0.0005, McNemar). The majority 
selected access, continuity, and patient efficiency of care as benefits and data quality as a barrier. 
Telehealth was felt to be most helpful for conditions relying on history, external exam, and 
previously collected ancillary testing and not helpful for conditions requiring funduscopic exam. 
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 Conclusions: Telehealth modality usage by neuro-ophthalmologists increased during the 
COVID-19 pandemic. Identified benefits have relevance both during and beyond COVID-
19.  Further work is needed to address barriers in their current and future states to maintain these 
modalities as viable care delivery options. 
 
Keywords: telehealth, telemedicine, video visits, neuro-ophthalmology, pandemic 
 
Introduction 
Telehealth, the delivery of healthcare services where patients and providers are separated by 
distance and sometimes time, was historically a relatively small component of the entire 
healthcare delivery system. During the COVID-19 pandemic, when minimizing face-to-face 
contact became a primary strategy to reduce virus transmission, public health policy changes 
incentivized health care providers and systems to accelerate implementation and utilization of 
telehealth services.(1, 2) While there are some universal benefits and challenges to the utilization 
of telemedicine, there are also specialty-specific nuances.(3) 
Before the COVID-19 pandemic, a minority of neuro-ophthalmologists utilized telehealth 
services to improve efficiency of and access to care.  As part of the audience response questions 
at a recent telehealth symposium, planned pre-COVID and delivered on March 9, 2020 at the 
annual meeting of the North American Neuro-Ophthalmology Society (NANOS), 4% of 
attendees reported utilizing telehealth video visits and 21% reported performing remote 
interpretation of testing as part of their clinical practice(personal communication, T. Thebeau, 
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 NANOS). The goal of this study is to characterize changes in telehealth utilization by neuro-
ophthalmologists during the COVID-19 pandemic as well as perceived benefits, barriers, and 
utility. Select synchronous and asynchronous telehealth methodologies were considered (Box 1). 
 
Methods 
This study is a survey of neuro-ophthalmologists in independent clinical practice. Exclusion 
criteria were non-independent practice (e.g. resident, fellow-in-training, or student) or inactive 
clinical practice (e.g. retirement). The population was sampled in a non-random fashion through 
an e-mail sent to members of NANOS, the largest organization in the world for the clinical 
subspecialty of neuro-ophthalmology, with 16% of members residing outside the US. The study 
was deemed exempt by the Stanford Institutional Review Board. Participants were survey 
respondents who agreed to the parameters of the study and confirmed eligibility prior to 
proceeding with survey questions. 
 
Survey content 
Demographic questions included country of residence, state of residence for US participants, age 
category, gender, and board certification(s) (neuro-ophthalmologists train initially in neurology 
and/or ophthalmology). Clinical practice questions included practice setting, proportion of 
income derived from clinical revenue, and electronic medical record (EMR) utilization, all of 
which were categorical. 
AC
CE
PT
ED
Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited.
 Participants were asked about use of synchronous (video visits) and asynchronous (remote 
interpretation of tests, second opinion reviews, e-consults) telehealth in their personal clinical 
practice before the COVID-19 pandemic (for US participants, prior to March 1, 2020), during 
the COVID-19 pandemic (March 1, 2020-through dates of survey May 1-15, 2020) and looking 
to the future. Telephone visits, virtual check-ins, and online patient portal communications were 
not included in this study. 
Perceived benefits of synchronous telemedicine (video visits) were collected only from those 
who use it, while all participants were asked about barriers. Questions about benefits and barriers 
were presented as multiple-choice responses where multiple responses could be selected. 
Additional comments were collected as free text. Participants were asked for their opinion 
(helpful, somewhat helpful, not helpful) on the utility of video visits in the evaluation and 
management of select neuro-ophthalmic conditions. See online supplemental material for full 
survey questions (Supplement 1,http://links.lww.com/WNO/A433). 
 
Survey delivery 
The survey was implemented on an electronic, web-based platform (Survey Monkey, San Mateo, 
CA) and distributed via e-mail to members of NANOS using the organization’s member listserv 
on May 1, 2020. Two additional reminders were sent. The survey was open from May 1-15, 
2020. No identifying information was collected. 
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 Analysis  
Responses to categorical survey questions are reported as proportions. Responses to numerical 
responses are reported as mean and 95% confidence interval. Responses to free text questions are 
reported qualitatively. Country of residence was collapsed to US and non-US due to small 
numbers in most non-US countries. For US participants, states were grouped by US census 
regions (west, midwest, south, northeast) for reporting purposes.  
Free-text comments for video platform use, benefits of video visits, and barriers to video visits 
were analyzed qualitatively through thematic grouping by the authors. For any comments on the 
same issue generated by multiple participants a new response category was generated for 
inclusion in quantitative analysis, noting that these are likely underestimates since they were not 
specifically queried as the other items were.  
Utilization of different telehealth modalities was compared between US and non-US participants 
for both the pre-COVID and peri-COVID time frames using Chi Square test or Fisher’s Exact 
test when a cell size was less than 10. Change in utilization of each telehealth modality was 
compared pre- and peri-COVID using McNemar’s test. Ordinal age and clinical revenue 
categories were compared between users and non-users of peri-COVID synchronous telehealth 
using Mantel Haenszel test for trend. Clinical practice environment and board certification were 
compared between users and non-users of peri-COVID synchronous telehealth using Chi Square. 
Proportions of participants perceiving barriers to use of synchronous telemedicine were 
compared between users and non-users of synchronous telemedicine peri-COVID using Chi 
Square. p<0.05 was the threshold for statistical significance. Statistical analysis was performed 
using SPSS 26 (IBM Inc.). 
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 Results 
The survey invitation was delivered by e-mail to 813 people (756 non-trainees). 214 responses 
were received. All confirmed independent practice and agreed to participation. 6 did not answer 
any questions beyond demographics and were excluded from further analysis. Thus, 208 
respondents were included in the final analysis (Table 1). The participants were mostly from the 
US (81.3%, Figure 1), with fairly even age and gender distribution. The US/non-US distribution 
is similar to that for NANOS membership (84% US, 16% non-US).  A recent comprehensive 
effort to count the number of neuro-ophthalmologists in the US identified 386 individuals in 
active clinical practice (187 clinical full time equivalents) (Personal communication, L. 
Frohman, NANOS). Thus we estimate that the US survey participants represent a 54% non-
randomized sample of the population of US-practicing neuro-ophthalmologists. 
Survey participants came from ophthalmology and neurology backgrounds (2:1). Multiple 
practice environments were represented with the majority in academic practice. Over half of 
participants derived more than 75% of their income from clinical revenue. Over 90% of 
participants reported using an EMR. About half had attended the telehealth symposium presented 
at the NANOS 2020 Annual Meeting on March 9, 2020. Among symposium attendees, two 
thirds reported participating in the audience response questions at the symposium. 
 
Video visits 
Prior to the COVID-19 pandemic, 3.9% (5.1% non-US, 3.6% US, p=0.65 Fisher’s Exact) of 
participants used video visits; of those participants using video visits, 87.5% performed 1-10 
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 video visits/week. 12.6% of non-users reported it was available to them. During the COVID-19 
pandemic, 68.3% (38.5% non-US, 75.1% US, p<0.0005, Chi Square) of participants used video 
visits (p<0.0005 vs. pre-COVID, McNemar; Figure 2A). This figure included all pre-COVID 
users, and 66.8% pre-COVID non-users. Among non-users, it was available to 33.4%, of interest 
to 38%, and not of interest to 29%.   
Video visit use peri-COVID was higher in younger survey participants (72.3 % < 35 years old, 
69.5% 35-44 years, 79.3% 45-54 years, 64% 55-64 years, 48.3 % ≥ 65 years old, p=0.04, 
Mantel-Haenszel test for trend) and among those with neurology board certification (84.3% vs. 
59.2% ophthalmology, p=0.001). Reasons for not adopting (available/not using, not 
available/interested, available/not interested) did not differ by board certification (p=0.88, Chi 
Square). Use was higher in academic, private solo/group, and private hospital based practice than 
government-based practice (73.1%, 64.5%, 75.0% vs. 27.3%, p=0.01 Chi Square). However, 
government-based practice participants were disproportionately outside the US (72.7%) which 
confounds this relationship. Use did not differ by proportion of revenue derived from clinical 
income (p=0.58, Mantel-Haenszel).  
The majority of peri-COVID video users (64%) saw 1-10 video visits/week. 27.4% saw 11-20 
and 3 participants saw >40. Many platforms were used, led by EMR integration (41.5%), with 
Zoom, Doxy.me, Facetime, and Doximity all having >10 users. Many users utilized more than 
one video platform.   
More than 50% of peri-COVID video users selected benefits of improved access to care, 
continuity of care, and efficiency of care for the patient (Figure 3). Selected barriers were similar 
between peri-COVID video users and non-users except for reimbursement (45% users, 30% non-
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 users, p=0.04 Chi Square) and data quality (90% users, 83% non-users, p= 0.01 Chi Square). 
Data quality was the barrier selected by the largest proportion of both video users and non-users 
(Figure 4). Free-text comments identified multiple other barriers and disadvantages of telehealth 
that had not been included in the multiple-choice options (Table 2).  Assuming continued 
telehealth reimbursement, 73.9% of users plan to continue video visits in their practice post 
public health emergency, while 17.6% are unsure. 
 
Remote interpretation of tests 
Prior to the COVID-19 pandemic, 26.7% of participants (28.7% US, 17.1% non-US, p=0.21, 
Fisher Exact) performed remote interpretation of tests with a mean of 4.7 /week (95% CI 3.4-6). 
Leading tests interpreted remotely were visual fields (87%) and OCT (79.6%). A minority 
remotely interpreted visual evoked potentials, electroretinography, and other testing. 17.8% of 
non-users preferred to see all patients having testing performed in person. 
During the COVID-19 pandemic, 32.2% of survey participants (30.7% US, 38.9% non-US, 
p=0.43 Fisher Exact) performed remote testing interpretation (p=0.09 vs. pre-COVID, 
McNemar) with a mean of 5.3 /week (95% CI 3.8-6.9). 22.2% of pre-COVID users ceased peri-
COVID, while 15.6% pre-COVID non-users adopted this practice (Figure 2B). One participant 
noted that in person testing was not being performed at their institution during the pandemic, 
which limited the opportunity. Ophthalmic imaging and visual fields remained the main types of 
tests being interpreted without seeing the patient. 84.6% of peri-COVID users plan to continue 
this practice, while 10.8% are unsure. 
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 Asynchronous telehealth 
Prior to the COVID-19 pandemic, 7.9% (6.6% US, 13.9% non-US, p=0.17 Fisher’s Exact) and 
4.4% (3.6% US, 8.3% non-US, p=0.20, Fisher’s Exact) of participants used online second 
opinions and e-consults respectively. During COVID-19, 15.3% (14.4% US, 19.4% non-US, 
p=0.45 Fisher’s Exact) of participants used online second opinions and 18.7% (18.6% US, 
19.4% non-US, p=1.0, Fisher’s Exact) used e-consults (p=0.001 second opinion, p <0.0005 e-
consult, vs. pre-COVID, McNemar, Figure 2C-D). A limitation to offering second opinion 
services was prohibition by the participant’s institution (24% pre-COVID, 17.8% peri-COVID).   
 
Perception of utility of synchronous telehealth (video visits) for select neuro-ophthalmic diseases 
Some participants did not respond to questions of video visit utility for neuro-ophthalmic 
conditions (Table 3, Figure 5). The number of responses per condition varied between 120-125; 
proportions are reported according to the number of participants who selected a category for each 
condition. Conditions for which >50% of participants indicated video visits are helpful were: 
migraine with aura (65.0%), pituitary tumor with prior visual fields, and magnetic resonance 
imaging (MRI) results (62.1%). Conditions for which >50% of participants indicated that video 
visits are not helpful were non-arteritic anterior ischemic optic neuropathy (NAION) (63.4%), 
possible arteritic ischemic optic neuropathy (60.5%), and optic atrophy (70.8%). 
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 Discussion 
Telehealth modalities as a way to deliver neuro-ophthalmic care have been of interest in the 
profession for many years, as demonstrated by inclusion of symposia on this topic in the annual 
meetings of the North American Neuro-ophthalmology Society in 2013 and 2020.(4, 5) During 
the COVID-19 pandemic, interest in and utilization in this area increased throughout the medical 
profession and in neuro-ophthalmology.(3, 6) In this study, we demonstrate increased telehealth 
utilization by neuro-ophthalmologists during the COVID-19 pandemic. It builds upon prior 
single institution qualitative reports by quantifying utilization by providers in different practice 
environments both in and outside of the US. In addition, a higher-level of evidence for perceived 
benefits, barriers and utilization is provided, building on what has been previously stated by 
expert opinion. 
Prior to COVID, the literature supported use of video visits and remote interpretation of testing 
for delivery of neuro-ophthalmic care.(7-9) However, participants both in and outside the US 
reported minimal use of video visits, on-line second opinions and e-consults and moderate use of 
remote testing interpretation pre-COVID, similar to what was reported using the audience 
response system at the 2020 NANOS telehealth symposium. Increased utilization peri-COVID 
occurred for all modalities, though this increase did not meet the threshold of statistical 
significance for remote interpretation of testing. Remote interpretation of testing was the only 
modality surveyed for which some participants ceased utilization peri-COVID. Based on a 
comment by one participant, this change is likely attributed to cessation of all in-person testing in 
some practice environments during COVID-19. 
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 Increase in telehealth modality utilization occurred for both US and non-US participants. 
Adoption was greatest in the younger survey respondents (<35 years old) which may reflect the 
greater numbers of digital natives within this age demographic.(10) Participants board-certified 
in neurology were higher adopters, in line with the more established role of synchronous 
telemedicine in neurology,(11) whereas ophthalmology telemedicine has traditionally focused 
more on remote imaging with automated interpretation.(12) There was no association between 
telehealth adoption and proportion of income derived from clinical revenue. While this lack of 
association may speak to altruistic motives for provision of care via telehealth modalities, such a 
conclusion is speculative since participants’ motivations were not queried. 
While this survey did not explore the full extent of telehealth’s impact on patient care, 
participants endorsed many benefits. However, the relative merit of these benefits is situational, 
currently consisting of a global pandemic. It remains to be seen how these benefits are valued as 
traditional methods of care delivery resume. This benefit is particularly relevant to neuro-
ophthalmology where improved patient access and increased efficiencies facilitated by telehealth 
may address shortfalls in provider access, who are concentrated in major cities and academic 
centers with an average wait time of 6 weeks, and over 20% of whom report wait times >3 
months (personal communication of internal NANOS survey, M. Moster, NANOS).    
Even among telehealth adopters, a high proportion of survey respondents identified data quality 
concerns including exam limitations as a significant barrier. This study did not ascertain which 
aspects of the exam posed the greatest barrier for telehealth implementation for our participants 
but based on participant responses regarding utility of telehealth in various conditions, we 
suspect that a primary challenge is obtaining a proper internal assessment of the eyes. Conditions 
for which video visits were deemed most helpful by participants were those primarily relying on 
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 history or external exam to inform management, and those for whom vision measurement and or 
visualization of the posterior fundus was accomplished through ancillary testing. In contrast, 
video visits were deemed not helpful for conditions relying on an ophthalmoscopic finding for 
diagnosis. Of note, there was no consensus on the helpfulness of video visits for any condition, 
highlighting the heterogeneity of clinical practice style among neuro-ophthalmologists. Studies 
to validate data acquired through telehealth methods will be important to optimize telehealth 
care. 
Differences in data acquired via telehealth and in-person visits, and the implications of basing 
management decisions on these, may be the cause of medical liability concerns.(13) Prior to 
COVID, telemedicine coverage was available as part of liability plans. During this pandemic, 
new federal acts grant immunity from liability for healthcare workers acting in good faith. 
Protections at the state level vary with many states amending existing Good Samaritan statutes to 
provide broad civil immunity to health care professionals during the pandemic.(14) 
In the US, telehealth reimbursement pre-COVID was restricted and disproportionately low 
compared to in-person visits, acting as a disincentive. Peri-COVID, CMS and many private 
insurers are covering telehealth visits at a level equivalent to in-person visits, effectively 
lowering this barrier.(15)  Future reimbursement regulations remain uncertain and continue to 
rapidly evolve. Regular provision of education regarding billing and coding for neuro-
ophthalmologists will be essential to lower these barriers. 
Beyond information technology infrastructure, implementation challenges of integrating video 
with in-person practice and lack of ancillary support for video visits in current practice models 
were identified by survey participants. These were noted to have negative impacts on provider 
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 wellness. Ongoing use and further adoption of telehealth modalities will require organizations to 
continue providing and improving telehealth infrastructure. Protocols for incorporating non-
provider staff into telehealth delivery, strategies to optimize patient selection, and scheduling to 
optimize both efficiency and outcomes and train trainees and providers will need to be expanded 
and refined.(16) 
Even when presuming continued telehealth reimbursement, over one quarter of peri-COVID 
video visit users either plan to discontinue or remain uncertain regarding future video visit 
utilization following the end of the public health emergency. This survey did not elicit responses 
for participants’ motives regarding their reluctance to continue telehealth services. Perhaps this 
reflects the favorable benefit:barrier ratio during this pandemic when traditional care delivery has 
not been possible; this ratio may revert post-COVID, resulting in increased barriers, both broadly 
(reimbursement, liability) and locally (practice delivery and efficiency).  
The main limitations of this study relate to the survey methodology used.(17) Specifically, 
sampling and questionnaire development were done in an accelerated fashion due to the time 
sensitivity of the research question. By collecting responses during the COVID-19 pandemic, 
recall bias was likely minimized. The non-randomized sample with voluntary response likely 
biased towards overestimates of adoption given that those not interested likely had reduced rates 
of participation. Benefits and barriers not specifically queried (e.g. patient technology issues) 
were likely underestimated. There were areas of interest not captured by the survey including use 
of phone calls, online portal and e-mail communications with patients, remote interpretation of 
patient submitted data, and “virtual check-in” encounters, as well as stratifying benefits and 
barriers pre-COVID, peri-COVID, and post-COVID. 
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 Conclusions 
During a time of pandemic, neuro-ophthalmologists have rapidly adopted telehealth by 17-fold, 
providing patients with continued access to care and partially recovering revenue lost due to 
public policies restricting traditional in-person clinical practice patterns. Similar to many 
neurological subspecialties and in contrast to other ophthalmic subspecialties, neuro-
ophthalmology is amenable to telehealth visits, which still allows for careful history taking and 
external examination to obtain actionable data for patient triage and management.(18)  The 
future of telehealth in neuro-ophthalmology remains uncertain. It is a promising modality for 
continued patient access and practice revenue, but barriers remain, including some that 
individual practitioners have limited control, such as federal and state policies on telehealth 
reimbursement and liability. Important areas for future study include the benefits of telehealth 
and patient access to neuro-ophthalmic care and strategies to address barriers under practitioners’ 
control including data quality, practice efficiency, and patient selection. 
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Box 1: Definitions of Telehealth Modalities Included in This Study 
 Video visits are real-time (synchronous) encounters between a provider and a patient 
separated by location. The provider is able to obtain a history from the patient, perform 
external examination, and review previous clinical data, then counsel the patient and 
make decisions for management of the patient’s care. Regulations on patient and provider 
location, medical liability, and billing and reimbursement have evolved rapidly during the 
pandemic. 
 Remote interpretation of testing is where the patient obtains a test separately from a direct 
encounter with a provider; the provider interprets the test and provides a report to a 
referring provider separately. Relevant tests in neuro-ophthalmology including visual 
fields, ophthalmic photography and electrophysiology. Excluded from this definition is 
the CPT/HCPCS code G2010 (remote review/interpretation of remote patient data), in 
which an established patient submits a photo or video to a provider for review and 
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 interpretation in order to determine whether or not the patient needs to be seen in person 
urgently. 
 Online second opinions are asynchronous encounters between the provider and a new 
patient (ie, not previously seen in their in-person practice). Typically they are 
administered through a third party vendor, are initiated by the patient and consist of the 
provider’s review of the patient’s medical records and patient questions, followed by a 
written report to the patient.(19, 20) 
 E-consults (or interprofessional consults) are asynchronous and sometimes synchronous 
encounters between the consulting provider and a referring provider about new or 
established patients without any communication with the patient. These consults are 
requested by the referring provider (with patient consent) and consist of review of the 
patient’s medical records by the consulting provider and sometimes verbal discussion 
with the referring provider. The consulting provider then provides a written report to the 
referring physician. This definition is in accordance with the CPT/HCPCS codes 99446-
99449 and 99451. 
 
Table Legends: 
Table 1: Description of Survey Participants 
 
Table 2. Additional barriers to video telehealth generated by participants 
 
Table 3: Perception of video telehealth utility in select neuro-ophthalmic conditions 
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 Figure Legends: 
 
Figure 1:  Geographic Distribution of Survey Participants.  Shade of world map (upper) and US 
map (lower) corresponds to number of participants from each country (upper) and US state 
(lower).  
 
Figure 2: Changes in Neuro-ophthalmologist Telehealth Service Utilization During the COVID-
19 Compared with Immediately Prior.  Each pie represents self-reported status of survey 
participants with regards to utilization of telehealth modalities in their clinical practice peri-
COVID according to pre-COVID utilization of different telehealth modalities (see box 1 for 
definitions): video visits (A), remote interpretation of ancillary testing (B), on-line second 
opinion (C), E-consult (D). 
 
Figure 3:  Benefits of Video Telehealth Selected by Neuro-ophthalmologists who are Users of 
Video Visits During COVID-19.  Each bar is the proportion of peri-COVID video users (n = 
141) who selected that item as a benefit to video telehealth.  Benefits are ordered by proportion 
of peri-COVID video users selecting it. 
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 Figure 4:  Barriers to Video Telehealth Selected by Neuro-ophthalmologists according to Video 
Telehealth User Status During COVID-19. Each bar is the proportion of peri-COVID video users 
(black, n = 141) or non-users (grey, n = 66) who selected that item as a barrier to video 
telehealth. Patient technology barrier was not included in the survey choices, but was added to 
the analysis based on inclusion in comments by multiple participants.  Barriers are ordered by 
proportion of peri-COVID video users selecting it.  
 
Figure 5: Perception of Video Telehealth Utility in Select Neuro-Ophthalmic Conditions.  Each 
stacked bar represents a condition, with colors representing proportion who gave a response for 
that condition (n=120-125) selecting that video telehealth is helpful (black), somewhat helpful 
(dark grey) or not helpful (light gray).  Conditions are ordered by proportion selecting “helpful”. 
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 Table 1: Description of Survey Participants 
 
Variable Distribution (n=208) 
Country 
US  
Non-US   
Missing   
 
169 (81.3%)  
39 (18.8%) 
0 
Region (amongst US participants) 
West                  
Midwest            
South                 
Northeast          
Missing              
 
34 (20.2%) 
40 (23.8%) 
50 (29.8%) 
44 (26.2%) 
1 
Age (years) 
< 35           
35-44       
45-54        
55-64          
> 65              
Missing          
 
11 (5.3%) 
59 (28.5%) 
58 (28%) 
50 (24%) 
29 (14%) 
1  
Gender 
Female        
Male            
Other                 
Missing           
 
104 (50.2%) 
103 (49.8%) 
0 
1 
Board certification 
Ophthalmology         
Neurology            
Both                
Missing           
 
130 (63.1%) 
70 (34%) 
5 (2.9%) 
2 
Practice setting 
Academic                 
Government             
Private solo/group     
Private hospital            
Missing                       
 
119 (57.2%) 
11 (5.3%) 
62 (29.8%) 
16 (7.7%) 
0 
Proportion of income derived from clinical 
revenue 
0-25%          
26-50%          
51-75%         
> 75%              
Missing             
 
 
40 (19.2%) 
25 (12%) 
33 (15.9%) 
110 (52.8%) 
0   
AC
CE
PT
ED
Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited.
 Table 2. Additional barriers to video telehealth generated by participants 
Wellness - More physically draining than face-to-face to maintain engagement with 
patients 
Technology - Variable reliability of live video technologies 
- Video doesn’t offer much more than phone for ophthalmology 
Patient Buy-
In 
- Patient dissatisfaction with billing 
- Patients not convinced by telemedicine 
Quality of 
Care 
- Decreased precision and comprehensiveness of exam 
Efficiency and 
Scheduling 
- Learning curve for incorporating video telemedicine into daily clinic 
flow 
 Increased time to prepare for each visit 
- Video telemedicine visits may take extra time, resulting in decreased 
clinic volumes 
Limited 
Support 
- Not utilizing technicians or medical assistants for intake and 
questionnaires 
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 Table 3: Perception of video telehealth utility in select neuro-ophthalmic conditions 
Helpful - Cranial nerve palsy(ies) 
- Migraine with aura 
- Optic neuritis with visual fields (VF), magnetic resonance imaging 
(MRI), and optic disc photos or optical coherence tomography (OCT) 
- Pituitary tumor with VF, MRI, OCT 
- Positive visual phenomenon 
- Pseudotumor cerebri/idiopathic intracranial hypertension with VF 
and optic disc photos or OCT 
Somewhat 
Helpful 
- Anisocoria 
- Binocular diplopia 
- Eye pain with normal eye exam 
- (Ocular) myasthenia gravis 
- Ptosis 
- Transient visual loss 
- Stable established patient with afferent visual pathway disease 
Not Helpful - Non-arteritic anterior ischemic optic neuropathy (NAION) 
- Possible arteritic ischemic optic neuropathy 
- Optic atrophy 
 
  
AC
CE
PT
ED
Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited.
  
Figure 1 
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Figure 2 
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Figure 3 
  
AC
CE
PT
ED
Copyright © North American Neuro-Ophthalmology Society. Unauthorized reproduction of this article is prohibited.
  
Figure 4 
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Figure 5 
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